Company: SPEG
Filing Date: 2025-07-15
Form Type: 424B4
Source: 0001213900-25-064326
Chunk: 172

Company: Silver Pegasus Acquisition Corp.
Filing Date: 2025-07-15
Form: 424B4
Chunk 172
---
’s ongoing assessment of all factors related to our potential status under the Investment Company Act), instruct the trustee to liquidate the investments held in the trust account and instead to hold the funds in the trust account in cash or in an interest bearing demand deposit account at a bank. Due to the short -termnature of these investments, we believe there will be no associated material exposure to interest rate risk. 106 Related Party Transactions In June 2024, our sponsor paid $25,000, or approximately $0.006 per share, to cover certain of our offering costs in exchange for 4,312,500 Class B ordinary shares or founder shares (or $0.007 per share for 3,750,000 founder shares if the underwriters do not exercise the over -allotmentoption and 562,500 founder shares are forfeited as a result). Subsequently, on February6, 2025, the Company, through a share capitalization, issued the sponsor an additional 1,437,500 Class B ordinary shares as bonus shares, bringing the aggregate number of founder shares to 5,750,000. On May7, 2025, the Sponsor surrendered 1,916,667 Class B ordinary shares, leaving 3,833,333 Class B ordinary shares, at a price per share of approximately $0.0075. The number of founder shares outstanding was determined based on the expectation that the total size of this offering would be a maximum of 11,500,000 units if the underwriters’ over -allotmentoption is exercised in full, and therefore that such founder shares would represent 25% of the outstanding shares after this offering. Up to 500,000 of the founder shares will be surrendered for no consideration depending on the extent to which the underwriters’ over -allotmentis exercised. Our sponsor and Roth have committed to, pursuant to written agreements, to purchase an aggregate of 3,250,000 private placement warrants (whether or not the underwriters’ over -allotmentoption is exercised in full), at a price of $1.00 per private placement warrant, or $3,250,000 in the aggregate (, in a private placement that will close simultaneously with the closing of this offering. Of those 3,250,000 private placement warrants, our sponsor has agreed to purchase 2,000,000 private placement warrants (whether or not the underwriters’ over -allotmentoption is exercised in full) and Roth has agreed